Enanta Pharmaceuticals
ENTA
#7670
Rank
A$0.51 B
Marketcap
A$17.72
Share price
-2.64%
Change (1 day)
94.99%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: A$0.51 Billion

As of March 2026 Enanta Pharmaceuticals has a market cap of A$0.51 Billion. This makes Enanta Pharmaceuticals the world's 7670th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.51 B-29.18%
2025A$0.72 B254.56%
2024A$0.20 B-29.59%
2023A$0.29 B-79.54%
2022A$1.42 B-32.78%
2021A$2.11 B92.39%
2020A$1.09 B-37.11%
2019A$1.74 B-10.54%
2018A$1.95 B35.93%
2017A$1.43 B62.46%
2016A$0.88 B3.87%
2015A$0.85 B-26.34%
2014A$1.15 B110.48%
2013A$0.54 B

End of Day market cap according to different sources

On Mar 28th, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

A$0.51 Billion
by Nasdaq info icon info icon
A$0.51 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$843.06 B 163,841.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$416.75 B 80,940.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
A$538.87 B 104,687.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$160.06 B 31,025.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$430.32 B 83,580.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$173.89 B 33,715.62%๐Ÿ‡บ๐Ÿ‡ธ USA